Jamshid Hadjati
Tehran University of Medical Sciences
H-index: 32
Asia-Iran
Top articles of Jamshid Hadjati
Title | Journal | Author(s) | Publication Date |
|---|---|---|---|
PX-478, an HIF-1α inhibitor, impairs mesoCAR T cell antitumor function in cervical cancer | Frontiers in Oncology | Ahmad Reza Panahi Meymandi Behnia Akbari Tahereh Soltantoyeh Zahra Shahosseini Mina Hosseini | 2024/2/15 |
Anti-CTLA-4 nanobody as a promising approach in cancer immunotherapy | Mehregan Babamohamadi Nastaran Mohammadi Elham Faryadi Maryam Haddadi Amirhossein Merati | 2024/1/8 | |
PGE2-EP2/EP4 signaling elicits mesoCAR T cell immunosuppression in pancreatic cancer | Frontiers in Immunology | Behnia Akbari Tahereh Soltantoyeh Zahra Shahosseini Farhad Jadidi-Niaragh Jamshid Hadjati | 2023/6/30 |
The inhibitory receptors PD1, Tim3, and A2aR are highly expressed during mesoCAR T cell manufacturing in advanced human epithelial ovarian cancer | Cancer Cell International | Behnia Akbari Tahereh Soltantoyeh Zahra Shahosseini Fariba Yarandi Jamshid Hadjati | 2023/5/27 |
MicroRNA-124 Enhances T Cells Functions by Manipulating the Lactic Acid Metabolism of Tumor Cells | Iranian Journal of Allergy, Asthma and Immunology | Mohammad Khakpoor-Koosheh Hosein Rostamian Elham Masoumi Leila Jafarzadeh Keyvan Fallah-Mehrjardi | 2023/2/25 |
Crosstalk between autophagy and metabolic regulation of (CAR) T cells: therapeutic implications | Ahmad Reza Panahi Meymandi Behnia Akbari Tahereh Soltantoyeh Jamshid Hadjati Daniel J Klionsky | 2023/8/22 | |
Cell therapy is a distinguished targeted immunotherapy with great potential to treat solid tumors in the new era of cancer treatment. Cell therapy products include genetically … | Adoptive cellular therapies in immunoregulation and cancer | Jamshid Hadjati Youwei Zhang Ning Li Erxi Wu | 2023/7/5 |
Remarkable Effect of Increasing Glutamine Metabolism on Caveolin-1 in Breast Cancer: A Brief Report | Samaneh Mostafavi Jamshid Hadjati Amrollah Mostafazadeh Zuhair Mohammad Hassan | 2022/9/23 | |
Agent-based modeling of tumor and immune system interactions in combinational therapy with low-dose 5-fluorouracil and dendritic cell vaccine in melanoma B16F10 | Iranian Journal of Allergy, Asthma and Immunology | Sarah Rahbar Sajad Shafiekhani Armin Allahverdi Arezoo Jamali Nasim Kheshtchin | 2022/4/11 |
HIGHLY EFFICIENT GENERATION OF TRANSGENICALLY AUGMENTED CAR NK CELLS OVEREXPRESSING CXCR4 | Frontiers in immunology | Arezoo Jamali Jamshid Hadjati Zahra Madjd Hamid Reza Mirzaei Frederic B Thalheimer | 2020/8/28 |
Identification of the optimal pattern of the injection and dosage of DC immunotherapy using the mathematical models based on ordinary differential equations | Iranian Journal of Immunology | Bahareh Zand Samaneh Arab Nasim Kheshtchin Abazar Arabameri | 2022 |
Soluble and immobilized anti-CD3/28 distinctively expand and differentiate primary human T cells: an implication for adoptive T cell therapy | Iranian Journal of Allergy, Asthma and Immunology | Tahereh Soltantoye Behnia Akbari Hamid Reza Mirzaei Jamshid Hadjati | 2022/12/24 |
Targeting hypoxia and hypoxia‐inducible factor‐1 in the tumor microenvironment for optimal cancer immunotherapy | Nasim Kheshtchin Jamshid Hadjati | 2022/2 | |
A novel formulation of cyclosporine A/phosphatidylserine-containing liposome using remote loading method: Potential product for immunosuppressive effects | Journal of Drug Delivery Science and Technology | Seyed Ali Nazeri Seyed Mahdi Rezayat Amir Amani Jamshid Hadjati Alireza Partoazar | 2022/11/1 |
Restricting Tumor Lactate Metabolism using Dichloroacetate Improves T Cell Functions | Hosein Rostamian Mohammad Khakpoor-Kooshe Leila Jafarzadeh Elham Masoumi Keyvan Fallah-Mehrjardi | 2021/4/27 | |
Prediction of anti-CD25 and 5-FU treatments efficacy for pancreatic cancer using a mathematical model | BMC cancer | Sajad Shafiekhani Hojat Dehghanbanadaki Azam Sadat Fatemi Sara Rahbar Jamshid Hadjati | 2021/12 |
Extracting mutual interaction rules using fuzzy structured agent-based model of tumor-immune system interactions | Journal of Biomedical Physics & Engineering | A Allahverdy S Rahbar HR Mirzaei M Ajami A Namdar | 2021/2 |
CRISPR/Cas9-mediated TGFβRII disruption enhances anti-tumor efficacy of human chimeric antigen receptor T cells in vitro | Journal of translational medicine | Khadijeh Alishah Matthias Birtel Elham Masoumi Leila Jafarzadeh Hamid Reza Mirzaee | 2021/12 |
Genetic modification of cytokine signaling to enhance efficacy of CAR T cell therapy in solid tumors | Navid Ghahri-Saremi Behnia Akbari Tahereh Soltantoyeh Jamshid Hadjati Saba Ghassemi | 2021/10/14 | |
Epigenetic strategies to boost CAR T cell therapy | Behnia Akbari Navid Ghahri-Saremi Tahereh Soltantoyeh Jamshid Hadjati Saba Ghassemi | 2021/9/1 |
